Bioactive prenylated c6–c3 derivatives from the roots of Illicium brevistylum

IF 1.3 3区 医学 Q3 CHEMISTRY, APPLIED
{"title":"Bioactive prenylated c6–c3 derivatives from the roots of Illicium brevistylum","authors":"","doi":"10.1080/10286020.2024.2365437","DOIUrl":null,"url":null,"abstract":"<div><div>Three new prenylated C<sub>6</sub>–C<sub>3</sub> compounds (<strong>1–3</strong>), together with two known prenylated C<sub>6</sub>–C<sub>3</sub> compounds (<strong>4–5</strong>) and one known C<sub>6</sub>–C<sub>3</sub> derivative (<strong>6</strong>), were isolated from the roots of <em>Illicium brevistylum</em> A. C. Smith. The structures of <strong>1–3</strong> were elucidated by spectroscopic methods including 1D and 2D NMR, HRESIMS, CD experiments and ECD calculations. The structure of illibrefunone A (<strong>1</strong>) was confirmed by single-crystal X-ray diffraction analysis. All compounds were evaluated in terms of their anti-inflammatory potential on nitric oxide (NO) generation in lipopolysaccharide-stimulated murine RAW264.7 macrophages and murine BV2 microglial cells, antiviral activity against Coxsackievirus B3 (CVB3) and influenza virus A/Hanfang/359/95 (H3N2). Compounds <strong>3</strong> and <strong>4</strong> exhibited potent inhibitory effects on the production of NO in RAW 264.7 cells with IC<sub>50</sub> values of 20.57 and 12.87 μM respectively, which were greater than those of dexamethasone (positive control). Compounds <strong>1</strong> and <strong>4–6</strong> exhibited weak activity against Coxsackievirus B3, with IC<sub>50</sub> values ranging from 25.87 to 33.33 μM.</div></div>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Asian Natural Products Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/org/science/article/pii/S1028602024000869","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0

Abstract

Three new prenylated C6–C3 compounds (1–3), together with two known prenylated C6–C3 compounds (4–5) and one known C6–C3 derivative (6), were isolated from the roots of Illicium brevistylum A. C. Smith. The structures of 1–3 were elucidated by spectroscopic methods including 1D and 2D NMR, HRESIMS, CD experiments and ECD calculations. The structure of illibrefunone A (1) was confirmed by single-crystal X-ray diffraction analysis. All compounds were evaluated in terms of their anti-inflammatory potential on nitric oxide (NO) generation in lipopolysaccharide-stimulated murine RAW264.7 macrophages and murine BV2 microglial cells, antiviral activity against Coxsackievirus B3 (CVB3) and influenza virus A/Hanfang/359/95 (H3N2). Compounds 3 and 4 exhibited potent inhibitory effects on the production of NO in RAW 264.7 cells with IC50 values of 20.57 and 12.87 μM respectively, which were greater than those of dexamethasone (positive control). Compounds 1 and 4–6 exhibited weak activity against Coxsackievirus B3, with IC50 values ranging from 25.87 to 33.33 μM.
从Illicium brevistylum的根中提取的具有生物活性的前炔基c6-c3衍生物。
从 Illicium brevistylum A. C. Smith 的根中分离出了三种新的前烯化 C6-C3 化合物(1-3),以及两种已知的前烯化 C6-C3 化合物(4-5)和一种已知的 C6-C3 衍生物(6)。通过光谱方法,包括一维和二维核磁共振、HRESIMS、CD 实验和 ECD 计算,阐明了 1-3 的结构。通过单晶 X 射线衍射分析证实了伊利布酮 A (1) 的结构。评估了所有化合物在脂多糖刺激的小鼠 RAW264.7 巨噬细胞和小鼠 BV2 微神经胶质细胞中产生一氧化氮(NO)的抗炎潜力,以及对柯萨奇病毒 B3(CVB3)和流感病毒 A/HANfang/359/95 (H3N2)的抗病毒活性。化合物 3 和 4 对 RAW 264.7 细胞中 NO 的产生具有强效抑制作用,IC50 值分别为 20.57 和 12.87 μM,高于地塞米松(阳性对照)。化合物 1 和 4-6 对柯萨奇病毒 B3 的活性较弱,IC50 值在 25.87 至 33.33 μM 之间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
5.90%
发文量
47
审稿时长
2.3 months
期刊介绍: The Journal of Asian Natural Products Research (JANPR) publishes chemical and pharmaceutical studies in the English language in the field of natural product research on Asian ethnic medicine. The journal publishes work from scientists in Asian countries, e.g. China, Japan, Korea and India, including contributions from other countries concerning natural products of Asia. The journal is chemistry-orientated. Major fields covered are: isolation and structural elucidation of natural constituents (including those for non-medical uses), synthesis and transformation (including biosynthesis and biotransformation) of natural products, pharmacognosy, and allied topics. Biological evaluation of crude extracts are acceptable only as supporting data for pure isolates with well-characterized structures. All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two expert referees.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信